To amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. OTC Monograph Drug User Fee Transparency Act. S. 2513. 119th
Cong., 1st
sess., Introduced in Senate July 29, 2025. https://www.govinfo.gov/app/details/BILLS-119s2513is.
APA
Congress, Senate (2025, July 29). OTC Monograph Drug User Fee Transparency Act (S. 2513 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s2513is.
MLA
United States, Congress, Senate. OTC Monograph Drug User Fee Transparency Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s2513is. 119th Congress, S. 2513, Introduced in Senate 29 Jul. 2025.
Bluebook
S.2513 - 119th Congress (2025-2026): OTC Monograph Drug User Fee Transparency Act, S.2513, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s2513is.
